This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cooke, J. P. Articles by Huang, P. Search for Related Content PubMed PubMed Citation Articles by Cooke, J. P. Articles by Huang, P.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1128.)
© 2003 American Heart Association, Inc.

Letters to the Editor

A Peculiar Result and a Fanciful Hypothesis Regarding L-Arginine

John P. Cooke; Karsten Sydow

Program in Vascular Medicine and Biology, Stanford University School of Medicine, Calif

An extract of the first 250 words of the full text is provided, because this article has no abstract.

To the Editor:

In the January 2003 issue of this Journal, Chen et al¹ observed that L-arginine supplementation did not affect lesion formation in the hypercholesterolemic apolipoprotein E knockout mice, and it negated the protective effect that iNOS gene deficiency has in this model. Their findings are discordant with those observed in most other hypercholesterolemic models in which the administration of supplemental L-arginine improves vasodilation, increases endothelial synthesis of NO, reduces the generation of superoxide anion, suppresses the activation of oxidant sensitive transcriptional proteins, and reduces monocyte adhesion, infiltration, and lesion formation.^2–7 In most hypercholesterolemic models, L-arginine appears to be rate-limiting for the synthesis of NO. This may be due to increases in plasma asymmetric dimethylarginine (ADMA, an endogenous NOS inhibitor), expression of tissue arginase, or NO synthase uncoupling.^8–10

Attempting to explain the results of Chen et al, in his editorial Loscalzo¹¹ proposes the fanciful hypothesis that supplemental L-arginine could increase plasma levels of homocyst(e)ine, a substance known to induce endothelial dysfunction and atherosclerosis. Unfortunately, this hypothesis lacks any mechanistic basis or experimental support. Loscalzo notes correctly that L-arginine is a precursor for guanidinoacetate (GAA), a reaction catalyzed by L-arginine:glycine amidinotransferase (AGAT). The methylation of GAA by S-adenosylmethionine yields creatine and S-adenosylhomocysteine. Loscalzo speculates that supplemental arginine could increase homocysteine by this pathway. However, the article he cites to support his speculation revealed that GAA, not L-arginine, increased homocysteine levels in Sprague-Dawley rats.¹² Notably, GAA markedly suppressed the activity of AGAT. . . . [Full Text of this Article]

Jiqiu Chen; Paul Huang

Cardiovascular Research Center, Charlestown, Mass

This article has been cited by other articles:

				N. R. Madamanchi, A. Vendrov, and M. S. Runge Oxidative Stress and Vascular Disease Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 29 - 38. [Abstract] [Full Text] [PDF]

				M. M. Parnell, J. P. F. Chin-Dusting, J. Starr, and D. M. Kaye In vivo and in vitro evidence for ACh-stimulated L-arginine uptake Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H395 - H400. [Abstract] [Full Text] [PDF]